Skip to main content
. 2018 Mar 2;235(4):1283–1294. doi: 10.1007/s00213-018-4844-5

Table 1.

Mean (SE) of laboratory tests, overall effects of treatment, and paired sample t tests

Mean (SE) Overall effect Paired t tests
Test Time of testing OXA10 (n = 21) OXA30 (n = 22) DIA10 (n = 21) PBO (n = 22) F P OXA10-PBO OXA30-PBO DIA 10-PBO
Highway driving test
 SDLP (cm) + 4 h 18.47 (0.90) 24.15 (1.36) 19.47 (0.89) 16.58 (0.65) 19.67 < 0.001 < 0.01 < 0.001 < 0.001
Psychomotor vigilance test
Inverse reaction time + 2 h
+ 6 h
4.07 (0.09)
4.13 (0.09)
3.35 (0.14)
3.85 (0.13)
3.86 (0.10)
4.13 (0.10)
4.14 (0.09)
4.13 (0.11)
13.40
NS
< 0.001 < 0.001 < .001
 Lapses (#)* + 2 h
+ 6 h
0.90 (1.38)
1.19 (0.72)
11.86 (3.15)
4.77 (1.79)
2.29 (0.74)
0.90 (0.31)
0.64 (0.16)
0.77 (0.29)
χ 2 = 38.87
χ 2 = 10.29
< 0.001
< 0.05
< 0.001
< 0.01
< 0.05-
 Mean reaction time (ms) + 2 h
+ 6 h
258 (7)
254 (6)
454 (68)
311 (34)
277 (9)
255 (7)
251 (5)
255 (7)
4.61
NS
< 0.05 < 0.01 < 0.01
Critical tracking test
 Critical lambda (rad/s) + 2 h
+ 6 h
3.08 (0.12)
3.01 (0.14)
2.49 (0.13)
3.00 (0.13)
3.00 (0.09)
3.26 (0.11)
3.34 (0.10)
3.23 (0.11)
13.17
NS
< 0.001 < 0.05
-
< 0.001
-
< 0.01
-
Divided attention testa
 Primary task: z-AE + z-lg10(CL) + 2 h
+ 6 h
− 0.09 (0.46)
− 0.53 (0.38)
1.97 (0.53)
0.32 (0.45)
0.82 (0.36)
− 0.18 (0.39)
− 0.69 (0.36)
− 0.63 (0.38)
11.15a
NSa
< 0.01 < 0.001 < 0.01
 Secondary task: reaction time
(ms)
+ 2 h
+ 6 h
1966 (91)
1892 (81)
2323 (91)
2105 (70)
2152 (61)
1975 (80)
1883 (65)
1859 (74)
16.33a
NSa
0.001 < 0.001 < 0.001
Attention network test
 Mean total reaction time (ms) + 2 h
+ 6 h
584 (21)
558 (21)
730 (28)
626 (26)
630 (26)
594 (24)
547 (18)
560 (22)
26.48
6.67
< 0.001
< 0.01
0.001
-
< .001
< 0.001
< 0.001
< 0.05
 Conflict effect (ms) + 2 h
+ 6 h
124 (10)
120 (10)
148 (13)
128 (8)
125 (7)
127 (9)
105 (6)
116 (7)
5.57b
NS
< 0.01 < 0.05 < 0.01 < 0.05
 Orienting effect (ms) + 2 h
+ 6 h
49 (5)
54 (5)
68 (12)
63 (6)
63 (5)
51 (6)
47 (5)
51 (5)
9.82b
NS
0.001 < 0.01
 Alerting effect (ms) + 2 h
+ 6 h
53 (7)
48 (6)
71 (8)
64 (8)
58 (9)
61 (7)
63 (6)
52 (6)
NS
NS
Digit symbol substitution test
 Correct responses (#) + 2 h
+ 6 h
92.05 (2.97)
99.33 (2.64)
73.41 (3.05)
89.95 (2.26)
88.95 (2.83)
96.48 (2.89)
97.59 (2.23)
98.09 (2.89
22.71
6.80
< 0.001
< 0.01
< 0.01
-
< 0.001
0.001
< 0.001
-
Useful field of view c
 Total detection time (ms) + 2 h
+ 6 h
89 (7)
86 (6)
161 (23)
95 (6)
105 (10)
92 (9)
107 (14)
85 (7)
4.51c
NSc
0.02 0.02
Postural balance test
 Eyes open–ln area 95 (cm2) + 2 h
+ 6 h
0.69 (0.09)
0.38 (0.09)
1.48 (0.18)
0.87 (0.14)
0.79 (0.15)
0.90 (0.10)
0.26 (0.09)
0.51 (0.10)
10.10
5.88
< 0.001
< 0.01
< 0.01
-
< 0.001
< 0.05
0.01
0.001
 Eyes closed–ln area 95 (cm2) + 2 h
+ 6 h
1.01 (0.14)
0.68 (0.10)
1.58 (0.19)
1.25 (0.15)
1.02 (0.17)
0.80 (0.13)
0.70 (0.10)
0.71 (0.09)
6.56b
6.76
< 0.01
< 0.01
-
-
< 0.001
< 0.001
Determination test
 Median reaction time (ms) + 2 h
+ 6 h
740 (20)
706 (16)
810 (23)
739 (17)
767 (19)
707 (17)
714 (15)
689 (15)
8.14
NS
0.001 < 0.05 < 0.001 < 0.05
-
 Correct responses (#) + 2 h
+ 6 h
262 (9)
279 (7)
230 (11)
254 (10)
256 (8)
281 (7)
273 (8)
279 (9)
5.12
NS
0.01 -
-
0.001 -
-

SE standard error, OXA10 oxazepam 10 mg, OXA30 oxazepam 30 mg, DIA10 diazepam 10 mg, PBO placebo, SDLP standard deviation of lateral position, z-AE z-score of average tracking error, z-log(CL) z-score of log transformed number of control losses, ln natural log

“*”because assumptions for general linear model were violated, a non-parametric Friedman test was conducted with Wilcoxon signed-rank tests to examine drug-placebo contrasts

an = 10

bn = 19

cn = 14